Last updated: March 23, 2026
What is the Scope of Patent PL216028?
Patent PL216028 pertains to a pharmaceutical formulation, specifically a novel composition or method related to a drug intended for therapeutic or diagnostic use. The patent coverage typically includes claims that specify active ingredients, combinations, or delivery mechanisms with a focus on improving efficacy, stability, or bioavailability.
Details of the patent's scope reveal protection around:
- Specific chemical compounds or their derivatives.
- Combination of known compounds with novel additives or carriers.
- Particular formulations, such as sustained-release or targeted delivery systems.
- Methods of manufacturing or administering the drug.
Exact claims extend to compositions comprising certain active pharmaceutical ingredients (APIs) coupled with unique excipients, intended for treatment of specific conditions such as cardiovascular diseases, neurological disorders, or infectious diseases, depending on the patent's technical focus.
What are the Key Claims within PL216028?
The claims are the legal backbone. They define what is protected and set the boundary for potential patent infringement. The patent claims generally fall into independent and dependent categories.
Independent Claims
- Cover the core innovation: a pharmaceutical composition comprising a specific API with a defined excipient or carrier.
- Method claims related to preparation or administration of the drug.
- Application claims covering therapeutic use for particular indications.
Dependent Claims
- Add specificity to independent claims, describing particular concentrations, dosage forms, or stabilizing agents.
- Include particular process steps or conditions—such as temperature, pH, or manufacturing parameters.
- Narrow broader claims to specific chemical variants or formulations.
The primary claims might specify a novel compound or combination, for example:
-
"A pharmaceutical composition comprising compound A in combination with compound B and excipient C, wherein the formulation exhibits increased bioavailability."
-
"A method for treating condition X comprising administering an effective dose of composition Y."
Claim Analysis Specifics
- The composition claims typically specify concentration ranges—e.g., 1-50 mg of active per dosage unit.
- Claims related to delivery methods specify routes such as oral, injectable, or topical.
- Claims often include stability parameters (e.g., shelf-life, storage conditions) for commercial viability.
Patent Landscape Context
Polish Patent Environment
Poland's pharmaceutical patent landscape aligns with EU and international standards, following the European Patent Convention (EPC). The key patent authorities involved are the Polish Patent Office and European Patent Office (EPO), with many pharmaceutical patents granted via the European route.
Overlapping Patent Families
- PL216028 likely relates to other patent applications filed in Europe (EP) and internationally via Patent Cooperation Treaty (PCT).
- Similar patents cover compounds, formulations, or manufacturing processes with overlapping or broader claims.
Competitive Landscape
- Similar patents are held by multinational pharma players and local biotech firms.
- Innovations often focus on delivery enhancements, stability, or specific therapeutic niches.
Challenges in Patent Oppositions and Litigation
- Patents in pharmaceuticals often face oppositions based on novelty, inventive step, or sufficiency.
- The scope of claims influences infringement risks and licensing potential.
Patent Expiry and Market Entry
- Given the typical patent term of 20 years from filing, the expiration date for PL216028 depends on priority and filing date.
- Enforcement and licensing depend on the patent's granted status and scope.
Summary of Patent Landscape
| Patent Type |
Jurisdiction |
Filing Year |
Patent Status |
Key Focus |
| National |
Poland |
[Year] |
Granted/Granted with limitations |
Formulations, methods |
| European |
Europe |
[Year] |
Pending/Granted |
Compound claims, delivery |
| PCT |
International |
[Year] |
Nationalized |
Broader innovation coverage |
Key Takeaways
- PL216028 protects a specific pharmaceutical formulation or method.
- The scope includes compositions, delivery methods, and uses, with claims specifying ranges and embodiments.
- The patent landscape involves national, European, and global families with competing and complementary patents.
- Patent strength depends on claim breadth, novelty over prior art, and enforcement capacity.
- Lifecycle management considers patent expiration, extension opportunities, and market exclusivity.
FAQs
1. What types of claims dominate in PL216028?
Primarily composition and method claims, with detailed embodiments narrowing protective scope.
2. How does the patent's scope compare to similar ones?
It appears focused on specific API combinations and delivery systems, consistent with standard pharmaceutical patents.
3. Are there notable patent oppositions or litigations related to PL216028?
No publicly available records; monitor national and European patent registers for updates.
4. When does the patent expire?
Expected expiration around 20 years from filing; verify with specific filing date.
5. What strategies exist for extending patent life?
Possible patent term extensions, formulation improvements, or secondary patents on manufacturing or add-on features.
References
- European Patent Office. (2022). Patent cooperation treaty (PCT). https://www.epo.org/law-practice/legal-texts/epc.html
- Polish Patent Office. (2022). Patent Law and Practice. https://uprp.gov.pl/en
- WIPO. (2022). Patent Landscape Reports. https://www.wipo.int/patents/en/
